• 2007

Company Description

Pathfinder Cell Therapy develops therapies for diseases causing organ-specific cell damage, including diabetes, renal disease, and so on.

athfinder Cell Therapy is developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. Pathfinder has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (“PCs”) themselves being incorporated into the new tissue.